VALBIOTIS (EPA:ALVAL)

PRESS RELEASE

published on 06/17/2024 at 17:40, 2 years 4 months ago

Valbiotis invited to present clinical results at the American Diabetes Association’s 84th Scientific Sessions
Valbiotis invited to present clinical results from TOTUM•63 Phase II/III REVERSE-IT study in prediabetes and type 2 diabetes at the American Diabetes Association’s 84th Scientific Sessions

Valbiotis American Diabetes Association TOTUM•63 Clinical Results Scientific Sessions
BRIEF

published on 06/06/2024 at 10:58, 2 years 4 months ago

Valbiotis Terminate Licensing Agreement with Nestlé Health Science

Licensing Agreement Valbiotis Diabetes Treatment TOTUM•63 Nestlé Health Science
PRESS RELEASE

published on 06/06/2024 at 10:53, 2 years 4 months ago

Valbiotis reaches an agreement to terminate its licensing and supply agreement with Nestlé Health Science
Valbiotis regains full ownership of TOTUM•63, a plant-based dietary supplement for prediabetes and early type 2 diabetes, after terminating agreement with Nestlé Health Science

Valbiotis Dietary Supplement TOTUM•63 Nestlé Health Science Prediabetes
BRIEF

published on 06/06/2024 at 10:49, 2 years 4 months ago

Valbiotis and Nestlé Health Science terminate their licensing and supply agreement

Valbiotis Intellectual Property TOTUM•63 Food Supplements Nestlé
BRIEF

published on 06/04/2024 at 08:05, 2 years 4 months ago

Valbiotis and Nestlé Health Science terminate their licensing agreement

Diabetes Valbiotis Intellectual Property Dietary Supplement Nestlé Health Science
PRESS RELEASE

published on 06/04/2024 at 08:00, 2 years 4 months ago

Valbiotis reaches an agreement to terminate its licensing and supply agreement with Nestlé Health Science
Valbiotis terminates licensing and supply agreement with Nestlé Health Science, securing full ownership of TOTUM•63 for diabetes treatment. Strategic control and future partnerships planned

Licensing Agreement Valbiotis Diabetes Treatment TOTUM•63 Nestlé Health Science
BRIEF

published on 05/24/2024 at 17:45, 2 years 5 months ago

VALBIOTIS: Monthly information on voting rights and shares as of May 17, 2024

Share Capital Voting Rights Euronext Actions Valbiotis
BRIEF

published on 05/22/2024 at 17:45, 2 years 5 months ago

Valbiotis launches its e-commerce site for Valbiotis®PRO Cholesterol

E-commerce Valbiotis Lipidrive Hypercholesterolemia Food Supplements
PRESS RELEASE

published on 05/22/2024 at 17:40, 2 years 5 months ago

Valbiotis launches its e-commerce site for the marketing of Valbiotis®PRO Cholestérol
Valbiotis launches its e-commerce site for the marketing of Valbiotis®PRO Cholestérol on schedule, making innovative products accessible to all, including the Valbiotis®PLUS range of natural dietary supplements

Digital Marketing Valbiotis Dietary Supplements Valbiotis®PRO Cholestérol E-commerce Site
BRIEF

published on 05/14/2024 at 08:35, 2 years 5 months ago

Valbiotis publishes its voting rights figures for April 2024

Share Capital Voting Rights Actions Euronext Growth Valbiotis

Published on 10/30/2026 at 23:35, 2 days 5 hours ago

Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 5 hours ago

Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 2 days 8 hours ago

CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 2 days 10 hours ago

Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 13 hours ago

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

View all ACCESSWIRE

Published on 11/01/2026 at 10:35, 18 hours 52 minutes ago

Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 1 day ago

2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 1 day 12 hours ago

SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 2 days 6 hours ago

EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 22:30, 2 days 6 hours ago

/C O R R E C T I O N - OCI Global/

View all EQS

Published on 10/30/2026 at 23:00, 2 days 6 hours ago

BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 20:42, 2 days 8 hours ago

TINC and PMV invest in Storm Group (B)
Published on 10/30/2026 at 18:00, 2 days 11 hours ago

2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 2 days 17 hours ago

Capital increase through exercise of subscription rights
Published on 10/30/2026 at 08:45, 2 days 20 hours ago

Share buyback

View all LES ECHOS COMFI WIRE

News